Dr Nicola Peel
DM, FRCP
Consultant Physician and Honorary Senior Clinical Lecturer in Metabolic Bone Medicine, Sheffield Teaching Hospitals NHS Foundation Trust
Research interests
• Evaluation of techniques used in the diagnosis and management of osteoporosis, including:
- measurement of bone mineral density of the peripheral skeleton
- use of biochemical markers of bone turnover to monitor treatment response in clinical practice
• Effects of the contraceptive agent, depot medroxyprogesterone acetate, on skeletal maturation
• Patients’ perceptions of research involvement
Clinical Responsibilities
• Supervision of multi-disciplinary clinical team and integration of clinical services with the Academic Unit, enabling early implementation of innovative techniques into clinical practice
• Introduction of Vertebral Fracture Assessment scanning into the fracture risk assessment pathway (FRAS pathway)
External positions
• Member of the Programme Committee and the Bone Densitometry Forum of the National Osteoporosis Society (NOS)
• Faculty member for the NOS certification course for bone densitometry
Key Publications
Paggiosi MA, Clowes JA, Finigan J, Naylor KE, Peel NF, Eastell R. Performance of Quantitative Ultrasound Measurements of Bone for Monitoring Raloxifene Therapy. J Clin Densitom. 2010 Sep 16. [Epub ahead of print] Abstract
Naylor KE, Clowes JA, Finigan J, Paggiosi MA, Peel NF, Eastell R. (2010) The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women. Bone. 46(3):592-7 Abstract
Walsh JS, Eastell R, Peel NF. (2010) Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density. Fertil Steril. 93(3):697-701. Abstract
Yang L, Peel N, Clowes JA, McCloskey EV, Eastell R. (2009) Use of DXA-based structural engineering models of the proximal femur to discriminate hip fracture. J Bone Miner Res. 24(1):33-42 Abstract
Walsh JS, Eastell R, Peel NF. (2008) Effects of Depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: a case-control study. J Clin Endocrinol Metab. 93(4):1317-23 Abstract
Ferrar L, Jiang G, Clowes JA, Peel NF, Eastell R. (2008) Comparison of densitometric and radiographic vertebral fracture assessment using the algorithm-based qualitative (ABQ) method in postmenopausal women at low and high risk of fracture. J Bone Miner Res. 23(1):103-11 Abstract
Clowes JA, Peel NF, Eastell R. (2006) Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice. Osteoporos Int. 17(9):1293-302 Abstract
Clowes JA, Eastell R, Peel NF. (2005) The discriminative ability of peripheral and axial bone measurements to identify proximal femoral, vertebral, distal forearm and proximal humeral fractures: a case control study. Osteoporos Int. 16(12):1794-802 Abstract
Clowes JA, Peel NF, Eastell R. (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab. 89(3):1117-23 Abstract
Ferrar L, Jiang G, Eastell R, Peel NF. (2003) Visual identification of vertebral fractures in osteoporosis using morphometric X-ray absorptiometry. J Bone Miner Res. 18(5):933-8 Abstract
